Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 45, Issue 1, 1999, Pages 41-49

  Miura, Junnosuke ^a   Uchigata, Yasuko ^a   Yokoyama, Hiroki ^a   Omori, Yasue ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

ACE gene; AGT gene; Diabetic nephropathy; Diabetic retinopathy; Insulin dependent diabetes mellitus

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; JAPAN; MALE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ALBUMINURIA; ANGIOTENSINOGEN; BLOOD PRESSURE; COHORT STUDIES; CREATINE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DNA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; JAPAN; MALE; MYOCARDIAL ISCHEMIA; OPHTHALMOSCOPY; PEPTIDYL-DIPEPTIDASE A; POINT MUTATION; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032767188     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00059-5     Document Type: Article

References (33)

1. Andrzej S., Krolewski A.S., Canessa M., Warram J.H., Laffel L.M.B., Christlieb A.R., Knowler W.C., Rand L.I. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. New Engl. J. Med. 318:1988;140-145.
2. Seaquist E.R., Goetz F.C., Rich S., Barbosa J. Familial clustering of diabeteic kidney disease, evidence for genetic susceptibility to diabetic nephropathy. New Engl. J. Med. 320:1989;1161-1165.
3. Fujisawa T., Ikegami H., Kawaguchi Y., Hamada Y., Ueda H., Shintani M., Fukuda M., Ogihara T. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia. 41:1998;47-53.
4. G. Penno, N. Chaturveri, P.J. Talmud, P. Cotroneo, A. Manto, M. Nannipieri, L.A. Luong, J.H. Fuller, EUCLID Study Group. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients. Diabetes 47 (1998)1507-1511.
5. X. Jeunemaitre, F. Soubrier, Y.V. Kotelevtsev, R.P. Lifton, C.S. Williams, Charru Anne, S.C. Hunt, P.N. Hopkins, R.R. Williams, J.M. Lalouel, P. Corvol. Molecular basis of hypertension: Role of angiotensinogen. Cell 71 (1992) 169-180.
6. Fogarty D.G., Harron C., Hughes A.K., Nevin N.C., Doherty C.C., Maxwell A.P. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes. 45:1996;1204-1208.
7. Ohno T., Kawazu S., Tomono S. Association analysis of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism. 45:1996;218-222.
8. Fujisawa T., Ikegami H., Shen G.O., Yamato E., Takekawa K., Nakagawa Y., Hamada Y., Ueda H., Rakugi H., Higami J., Ohishi M., Fujii K., Fukuda M., Ogihara T. AngiotensinI-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care. 18(7):1995;983-985.
9. Yokoyama H., Uchigata Y., Otani T., Maroyama A., Yano-Aoki K., Kanematsu S., Kasahara T., Matsuura N., Omori Y. Development of diabetic nephropathy in Japanese patients with insulin-dependent diabetes mellitus: Tokyo Women's Medical College epidemiologic study. J. Diab. Comp. 8:1994;7-12.
10. World Health Organization: WHO expert committee on Diabetes Mellitus, Technical report series (1985)727.
11. Joint National Committee. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 153 (1993) 154-183.
12. Nomura T., Odagiri R., Demura R., Akashi H., Demura H. Evaluation of a new radioimmunoassay kit for urinary albumin. J. Med. Pharmaceutical. Sci. 22:1989;213-220.
13. Kasahara Y., Ashihara Y. Colorimetry of angiotensin I - converting enzyme activity in serum. Clin. Chem. 27:1981;1922-1925.
14. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP-1) (dipeptidylcarboxypeptidase 1). Nucl. Acids Res. 20:1992;1433.
15. Lindpaintner K., Pfeffer M.A., Kreutz R., Stampfer M.J., Grodstein F., LaMotte F., Buring J., Hennekens C.H. A prospective evaluation of an angiotensinconverting-enzyme gene polymorphism and the risk of ischemic disease. New Engl. J. Med. 332:1995;706-711.
16. Odawara M., Matusnuma A., Yamashita K. A pitfall in the association study of ACE gene polymorphism. Diab. Care. 19:1996;543.
17. Caulfield M., Laveder P., Farrall M., Munroe P., Lawson M., Turner P., Clark A.J.L. Linkage of the angiotensinogen gene to essential hypertension. New Engl. J. Med. 330:1994;1629-1633.
18. Barley J., Blackwood A., Caeter N.D., Crews D.E., Cruickshank J.K., Jeffery S., Ogunlesi A.O., Sagnella G.A. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J. Hyperten. 12:1994;955-957.
19. Marre M., Bernadet P., Gallois Y., Savagner F., Gutene T.T., Hallab M., Cambiem F., Passa P., Gelas F.A. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes. 43:1994;384-388.
20. Marre M., Jeunemaitre X., Gallois Y., Rodier M., Chayellier G., Dusselier L. et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complication in insulin-dependent in insulin dependent diabetes. J. Clin. Invest. 99:1997;1585-1595.
21. Banas U., Schmidt A., Illievich A., Kiener H.P., Rabensteiner D., Kaider A., Prager R., Abrtahamian H., Irsigler K., Mayer G. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia. 40:1997;327-331.
22. S. Schmidt, N. Schone, E. Ritz, the Diabetic nephropathy study group: Association of ACE gene polymorphism and diabetic nephropathy? Kid Int 47 (1995) 1176-1181.
23. Ringel J., Beige J., Kunz R., Distler A., Sharma A.M.: Genetic variants of the reninangiotensin system, diabetic nephropathy and hypertension. Diabetologia. 40:1997;193-199.
24. Tarnow L., Cambien F., Rossing P., Nielsen F.S., Hansen B.V., Lecerf L., Poirier O., Danilov S., Parving H.H. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes. 44:1995;489-494.
25. Chowdhury T.A., Dronsfield M.J., Kumar S., Gough S.L.C., Gibson S.P., Khatoon A. et al. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia. 39:1996;1108-1114.
26. Nagi D.K., Mansfield M.W., Stickland M.H., Grant P.J. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diab. Med. 12:1995;997-1001.
27. Yokoyama H., Uchigata Y., Otani T., Saeki A., Aoki K., Kasahara T., Omori Y., Johnsen K.B. Metabolic regulation and microangiopathy in a cohort of Japanese IDDM-patients. Diab. Res. Clin. Pract. 29:1995;203-209.
28. Rigat B., Huben C., Gelas F.A., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I- converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1990;1343-1346.
29. Tiret L., Rigat B., Viskis S., Breda C., Corval P., Cambien F., Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-convening enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 51:1992;197-205.
30. Doi Y., Yoshizumi H., Yoshinari M., Iino K., Yamamoto M., Ichikawa K., Iwase M., Fujishima M. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia. 39:1996;97-102.
31. Tiret L., Kee F., Poirier O., Nicaud V., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Amouyel P., Cambien F. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 341:1993;991-992.
32. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., Tiret L., Amouyel P., Galas F.A., Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme in a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
33. Katsuya T., Koike G., Yee T.W., Sharpe N., Jackson R., Nonon R., Horinchi M., Pratt R.E., Dzau V.J., MacMahon S. Association of angiotensinogen gene T235M variant with increased risk of coronary heart disease. Lancet. 345:1995;1600-1603.